A comprehensive view of AstraZeneca AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
AstraZeneca AB Champions Health Equity, Cancer Elimination by 2030, and Sustainability in Industry-Shaping Initiatives
Published:
April 18, 2024
by Industry Intelligence Inc.
|
AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts
Published:
April 18, 2024
by PharmaBiz (India)
|
AstraZeneca Submits Costa Rican Patent Application for Fused Tricyclic Compounds Useful as Anticancer Agents
Published:
April 18, 2024
by Pharmaceutical Patent News
|
AstraZeneca Seeks Patent for Arginase Inhibitors and Methods of Use Thereof
Published:
April 18, 2024
by Pharmaceutical Patent News
|
AstraZeneca AB Celebrates 25 Years of Innovation, Leads in Workplace Excellence and Sustainability, and Champions Public Health and Neurodiversity Initiatives
Published:
April 17, 2024
by Industry Intelligence Inc.
|
Ask us about our R&D/Patents market view